Vanguard Group Inc. Acquires 213,033 Shares of Astrana Health, Inc. $ASTH

Key Points

• Vanguard Group Inc. increased its stake in Astrana Health, owning approximately 8.74% of the company after acquiring an additional 213,033 shares in the first quarter.
• Astrana Health reported a 34.7% increase in quarterly revenue to $654.81 million, although it missed earnings expectations with an EPS of $0.19.
• Several hedge funds have significantly increased their holdings in Astrana Health, with a combined 52.77% of the company's stock now owned by institutional investors.

Vanguard Group Inc. increased its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 4.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,898,992 shares of the company's stock after purchasing an additional 213,033 shares during the quarter. Vanguard Group Inc. owned 8.74% of Astrana Health worth $151,918,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quarry LP boosted its position in shares of Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock worth $57,000 after acquiring an additional 471 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Astrana Health by 3.9% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,505 shares of the company's stock worth $773,000 after acquiring an additional 915 shares in the last quarter. US Bancorp DE boosted its position in shares of Astrana Health by 21.3% during the 1st quarter. US Bancorp DE now owns 5,791 shares of the company's stock worth $180,000 after acquiring an additional 1,015 shares in the last quarter. MetLife Investment Management LLC boosted its holdings in shares of Astrana Health by 4.7% in the fourth quarter. MetLife Investment Management LLC now owns 26,284 shares of the company's stock valued at $829,000 after acquiring an additional 1,173 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its holdings in shares of Astrana Health by 19.9% in the fourth quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock valued at $225,000 after acquiring an additional 1,184 shares in the last quarter. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Trading Down 1.7%

Shares of ASTH stock traded down $0.5180 during mid-day trading on Monday, hitting $30.1620. 143,991 shares of the company's stock were exchanged, compared to its average volume of 338,830. Astrana Health, Inc. has a fifty-two week low of $21.20 and a fifty-two week high of $63.20. The stock has a 50-day simple moving average of $25.26 and a two-hundred day simple moving average of $28.57. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.52. The stock has a market cap of $1.69 billion, a price-to-earnings ratio of 59.17, a PEG ratio of 0.76 and a beta of 0.85.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.36 by ($0.17). Astrana Health had a return on equity of 3.43% and a net margin of 1.04%.The business had revenue of $654.81 million for the quarter, compared to analyst estimates of $639.13 million. During the same quarter last year, the business earned $0.40 EPS. Astrana Health's revenue for the quarter was up 34.7% compared to the same quarter last year. Astrana Health has set its Q3 2025 guidance at EPS. Equities analysts expect that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.